Medical destruction: It's not just a conspiracy theory

barbara

Pioneer Founding member
It's important to read this article and the one below it to understand how Big Pharma has politicians, the FDA, media, academia in its grasp. Stem cell clinics do not profit Big Pharma. Most are operated by doctors and use a patient's own stem cells. As I've said so many times before, the war on stem cell clinics is all about power, profit and politics.

Jon Rappoport
8-22-19

https://blog.nomorefakenews.com/2019/08/22/medical-destruction-its-not-just-a-conspiracy-theory/

We're now living in a time of accusations. A public official or mainstream press outlet doesn't like what they're hearing, and they say, "Well, that's just another conspiracy theory."

And then know-nothing people breathe a sigh of relief and move on. "Thank goodness THAT'S NOT REAL."

If enough authorities repeat "conspiracy theory," the truth goes begging.

In this case, the facts have arrived. What's missing is widespread knowledge of those facts. The mainstream press is a cover-up operation

Some people are just waking up to medical destruction, by way of news on the opioid epidemic. https://blog.nomorefakenews.com/category/opioids/

They're late to the party, but that's all right. They can catch up.

Here are a few horrific "catch-up" quotes. I'll discuss the source afterwards:

"...appropriately prescribed prescription drugs are the fourth leading cause of death...About 330,000 patients die each year from prescription drugs in the US and Europe."

"They [the drugs] cause an epidemic of about 20 times more [6.6 million per year] hospitalizations, as well as falls, road accidents, and about 80 million [per year] medically minor problems such as pains, discomforts, and dysfunctions that hobble productivity or the ability to care for others."

"Deaths from over medication, errors, and self-medication would increase these figures."

In other words, the 330,000 deaths per year, the 6.6 million hospitalizations per year, and the 80 million "medically minor" problems per year...all of this stems from CORRECTLY PRESCRIBED medicines.

The quotes come from the ASA [American Sociological Association] publication called Footnotes, in its November 2014 issue. The article is "The Epidemic of Sickness and Death from Prescription Drugs." The author of the article is Donald W Light.

Donald W Light is a professor of medical and economic sociology. He is a founding fellow of the Center for Bioethics at the University of Pennsylvania. In 2013, he was a fellow at the Edmond J. Safra Center for Ethics at Harvard. He is a Lokey Visiting Professor at Stanford University and a Fellow of the Royal Society of Medicine.

It's been my policy to quote medical analysts who have mainstream credentials, when it comes to adding up the results of medical-drug destruction.

I do this to show that, in refusing to fix the holocaust, the federal government, medical schools, and pharmaceutical companies can't claim their critics and detractors are "fringe researchers."

Believe me, the officials who should have been fixing the enormous tragedy for at least the past 15 years are intent on hiding it.

When you stop and think about the meaning of these medical numbers, one of the things you realize is: this massive destruction of life envelops whole countries.

It not only maims and kills, it brings emotional turmoil and loss to the families, friends, co-workers, and colleagues of those who are killed and maimed: the 330,000 who are killed and the 6.6 million who are hospitalized and the 80 million whose productivity is hobbled or whose ability to care for others is significantly diminished.

If you consciously set out to bring a nation to its knees, to kill it, to disable it, to make it unable to function at any reasonable level, you would be hard pressed to find a more effective long-term method than exposing the population to the US/European medical-drug cartel.

Donald Light is the editor of a book that ought to be studied at every college and medical school in the world: The Risks of Prescription Drugs (Columbia University Press). The basic research that led to his conclusions, cited above, come from that book. His website is http://PharmaMyths.net.
 

barbara

Pioneer Founding member
FDA and Congress Move to Stop Unproven Stem Cell Interventions

It's impossible to read the above article and not contrast it with the article below.
"330,000 deaths per year, the 6.6 million hospitalizations per year, and the 80 million “medically minor” problems per year…all of this stems from CORRECTLY PRESCRIBED medicines" VS a few dozen at most adverse reactions from stem cell therapies. With the epidemic of deaths from FDA approved medications, why is the FDA and Congress not using aggressive measures to go after the drug cartel that is killing so many people? MONEY, MONEY, MONEY. There is no other explanation other than Big Pharma has them all in its pocket.


FDA and Congress Move to Stop Unproven Stem Cell Interventions
Agency’s jurisdiction over regenerative therapies upheld in landmark court ruling
August 22, 2019
By: Liz Richardson

https://www.pewtrusts.org/en/research-and-analysis/articles/2019/08/22/fda-and-congress-move-to-stop-unproven-stem-cell-interventions

The Food and Drug Administration and members of Congress have taken important steps in recent months to protect consumers from unproven and risky stem cell products offered by hundreds of clinics nationwide. However, the agency needs to take broader action to deter businesses from selling interventions whose safety and effectiveness have not been proven to regulators.

Unproven and poorly manufactured stem cell products can seriously harm patients. In response to their increasing availability, FDA officials have used aggressive measures to remove high-risk treatments from the marketplace. For example, the agency sought a permanent injunction in 2018 to stop a Florida company from manufacturing or distributing “stromal vascular fraction” (SVF) products. These treatments involved extracting fat tissue from patients, processing the material, and injecting the manipulated cells into other body parts. Three people allege that they were blinded after the clinic injected SVF products into their eyes.

In a pivotal ruling in June this year, a federal court upheld the FDA’s injunction, rejecting the company’s argument that the agency lacks authority under federal law to regulate these products. Many other clinics across the nation—more than 700, according to one estimate—make or sell products using similar techniques or processes.

Although the FDA recognizes the therapeutic promise of stem cells, it has long warned of the public health threat posed by unapproved products. In 2017, the agency released four guidance documents that constitute its regulatory framework for regenerative medicine, a rapidly growing field that includes therapies derived from living human tissue. Among other goals, the framework aims to clarify the distinctions between products that are subject to the agency’s full drug approval requirements and those that are not. The recent court decision upholding the FDA injunction should encourage businesses and clinicians developing these products to make sure that they comply with the framework.

FDA leaders have pledged a risk-based approach to enforcement. Peter Marks, head of the agency’s Center for Biologics Evaluation and Research, told The Pew Charitable Trusts in May that the “FDA will continue to take steps in this area to prevent the use of unproven and potentially dangerous products through whatever enforceable legal means are necessary to protect the public.”

Only a few stem cell-based products have received FDA approval to treat certain blood cancers and immune system diseases. Still, businesses providing unapproved stem cell treatments have touted a wide range of benefits. The clinic in Florida, for example, claimed that its procedures could treat neurological, autoimmune, orthopedic, and degenerative diseases.

Lawmakers are also addressing these issues. In July, the House Energy and Commerce Committee sent a letter to the FDA expressing concern about the proliferation of such clinics and asking the agency for details on how it plans to bring them into compliance with federal regulations. In May, the House Appropriations Committee signaled its support for recent federal actions in a report accompanying an FDA funding bill. The committee’s message to the agency encouraged coordination with the Federal Trade Commission to optimize enforcement and consumer education activities.

The FDA and FTC share authorities in overseeing medical product claims, and both agencies have taken steps to hold clinics accountable. Most recently, the FDA sent a letter putting an Arizona-based company, along with its 50 affiliated centers and clinics, on notice for making unproven claims that its therapies could treat Lyme disease, diabetes, Parkinson’s disease, stroke, kidney failure, amyotrophic lateral sclerosis (ALS), and more. Such a letter could be the first step toward more aggressive actions, including product seizures and injunctions.

In another instance, the FTC in October settled a case against a California-based business that allegedly made deceptive and unsubstantiated claims that stem cell therapies could treat or cure conditions such as Parkinson’s, autism, cerebral palsy, and heart disease.

These actions—from the courts, regulators, and Congress—demonstrate a growing concern that patients could be harmed by unapproved stem cell-based products. Taken together, they set the stage for the FDA to step up efforts to protect people from stem cell interventions that have not been proven to be safe or effective.

Liz Richardson directs The Pew Charitable Trusts’ health care products project.
 
Top